Commentary

Video

Precision Epigenetic Targeting for Germinal Cancer Lymphomas

Author(s):

Jennifer Effie Amengual, MD

Jennifer Effie Amengual, MD, of Columbia University Hebert Irving Comprehensive Cancer Center, discusses precision epigenetic targeting for germinal cancer lymphomas.

Related Videos
Grzegorz S. Nowakowski, MD
Jasmin M. Zain, MD
Grzegorz S. Nowakowski, MD
Grzegorz S. Nowakowski, MD
Reid Merryman, MD
Partow Kebriaei, MD
Sonali M. Smith, MD
Grzegorz S. Nowakowski, MD
Marco Davila, MD, PhD
Geoffrey Shouse, DO, PhD
Related Content
Grzegorz S. Nowakowski, MD, consultant, Division of Hematology, enterprise deputy director, Clinical Research, Mayo Clinic Comprehensive Cancer Center
October 4th 2024

Emavusertib-Focused Research Is Poised to Expand the PCNSL Treatment Paradigm

Matthew Lunning, DO, FACP
December 21st 2023

Lunning and Mehta-Shah Unpack Treatment Needs and Future Directions in PTCL

Christopher A. Yasenchak, MD, of of Willamette Valley Cancer Institute and Research Center/US Oncology Research
September 7th 2024

Brentuximab Vedotin Triplet Continues to Improve R/R Diffuse Large B-Cell Lymphoma Outcomes

Matthew Lunning, DO, FACP
October 30th 2023

Lunning and Nastoupil Highlight Treatment Considerations and Ongoing Research in Follicular Lymphoma

Neha Mehta-Shah, MD, MSCI, assistant professor, Washington University
September 7th 2024

Histologic Distinctions and Optimized Imaging Carve New Paths for Individualized PTCL Management

Non-Hodgkin Lymphoma | Image Credit: © freshidea - stock.adobe.com
September 6th 2024

Subcutaneous Rituximab Remains Underutilized in Non-Hodgkin Lymphoma